Generative AI designs DNA that activates only in cancer cells; open-source Chorus lets agents talk to the genome

lucapinello · x · 2026-11-18

On the Galaxy Balance podcast, Locium co-founder Luca Pinello discusses generative AI for designing synthetic regulatory DNA that switches genes on only in target cells like cancer cells. Locium runs a closed loop: regulatory atlases → generative models (DNA-Diffusion, CODA) → massively parallel reporter assays validating hundreds of thousands of designs. Pinello authored enhancer work underpinning Casgevy, the first FDA-approved CRISPR therapy, and released Chorus, an open-source tool for AI agents to converse with the genome. The talk also covers AI-designed pathogen risks and agentic scientific discovery.

Original post →

More from Apps

Apps channel →